Substrate screening identifies a novel target sequence for the proteasomal activity regulated by ionizing radiation

Angela Broggini-Tenzer1, Andreas Hollenstein, Zbigniew Pianowski

  • 1Laboratory for Molecular Radiobiology, University Hospital Zurich, CH-8091 Zürich, Switzerland.

Proteomics
|December 4, 2009
PubMed

Insights

Ionizing radiation alters enzyme activity in tumor cells, revealing the proteasome

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Enzyme activity screening can uncover regulatory mechanisms and anti-cancer drug targets.
  • Ionizing radiation (IR) influences cellular processes, including enzyme regulation in tumor cells.

Purpose of the Study:

  • To develop and apply a novel screening technique to identify IR-regulated proteolytic activities in tumor cells.
  • To characterize a specific IR-down-regulated protease and its substrate.

Main Methods:

  • A novel screening technique was used to identify substrate peptide sequences with altered proteolytic activity upon IR exposure.
  • Protease-class-specific inhibitors and cleavage site analysis were employed to identify the enzyme responsible.
  • A warhead-inhibitor was synthesized to pinpoint the protease.
  • In vitro assays were performed to confirm substrate cleavage.

Main Results:

  • A specific substrate peptide showed reduced cleavage in IR-treated cell extracts compared to controls.
  • The proteasome was identified as the key protease responsible for cleaving the substrate.
  • The substrate sequence shares homology with a regulatory site on nucleoporin 50 (NUP50).
  • Site-specific cleavage of NUP50 by the proteasome was confirmed in vitro.

Conclusions:

  • Ionizing radiation modulates proteasome activity, affecting the cleavage of specific substrates.
  • The proteasome's interaction with nucleoporin 50 suggests a new regulatory pathway linking IR, proteasome function, and nuclear transport.

Related Concept Videos